Parambir S. Dulai
Gastroenterology
259 E Erie St Ste 1600
Lavin Family Pavilion
Chicago, IL 60611
Lavin Family Pavilion
Chicago, IL 60611
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 285 publications
Cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosis.
Journal: JCI insight
Published: July 21, 2026
Comparative genomic analysis of Bacteroides fragilis from intestinal and extra-intestinal sites.
Journal: Microbiology spectrum
Published: July 14, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.
Journal: Journal of Crohn's & colitis
Published: May 20, 2026
New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUC.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 11, 2026
Real-world patient characteristics, treatments, and outcomes during and after severe ulcerative colitis hospitalization.
Journal: Journal of Crohn's & colitis
Published: April 14, 2026
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward.
Journal: Expert review of gastroenterology & hepatology
Published: February 20, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing Is Effective and Safe in Older Patients With Crohn's Disease: A Post Hoc Analysis of the REACT2 Trial.
Journal: The American journal of gastroenterology
Published: January 13, 2026
Comparative effectiveness of mirikizumab and risankizumab in patients with ulcerative colitis: A propensity-matched cohort study.
Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
Published: January 06, 2026
A decade of clinical data with vedolizumab: the past, present, and future.
Journal: Therapeutic advances in gastroenterology
Published: December 15, 2025
Risk of Extra-Intestinal Solid Organ Malignancy in Patients with Inflammatory Bowel Disease: A Propensity-Matched Cohort Study.
Journal: Digestion
Published: December 15, 2025
Butyrate epigenetically licenses sustained epithelial-T cell crosstalk for intestinal immune tolerance.
Journal: Nature communications
Published: November 13, 2025
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis With Severe Endoscopic Disease.
Journal: The American journal of gastroenterology
Published: November 13, 2025
Last Updated: 09/26/2026